EXPRESSION OF GROWTH HORMONE AND GROWTH HORMONE RECEPTOR IN FIBROADENOMAS OF THE BREAST

被引:0
作者
Lenicek, Tanja [1 ]
Kasumovic, Dino [2 ]
Stajduhar, Emil [3 ]
Dzombeta, Tihana [2 ]
Jukic, Zoran [4 ]
Kruslin, Bozo [1 ,2 ]
机构
[1] Sestre Milosrdnice Univ Hosp Ctr, Ljudevit Jurak Dept Pathol, Zagreb, Croatia
[2] Univ Zagreb, Sch Med, Dept Pathol, HR-10000 Zagreb, Croatia
[3] Sestre Milosrdnice Univ Hosp Ctr, Dept Radiol, Zagreb, Croatia
[4] Nova Gradiska Gen Hosp, Dept Surg, Nova Gradiska, Croatia
关键词
Fibroadenoma; Growth hormone; Growth hormone receptor; FACTOR-I; CELL-PROLIFERATION; MAMMARY-GLAND; CANCER-RISK; INSULIN; CARCINOMA; GH; EPITHELIUM; DISORDERS; AXIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fibroadenoma is the most prevalent benign breast tumor. It consists of epithelial and stromal components. In general, breast tumors are highly hormonally dependent and growth hormone by its physiology may have a possible oncogenic potential. Therefore, the aim of this study was to determine the expression of growth hormone and growth hormone receptor in epithelial and stromal components of fibroadenomas. Study group included 30 randomly chosen fibroadenomas from female patients aged between 18 and 69 years. The expression of growth hormone and growth hormone receptor was defined in both histologic components of fibroadenomas. Growth hormone was expressed in 96.7% of both epithelial and stromal components of fibroadenomas, with stronger expression in the stromal component. The same percentage of positive reaction (96.7%) was obtained in the epithelial component of fibroadenomas for growth hormone receptor expression. Only 6.7% of stromal components tested for growth hormone receptor were positive. The high expression of growth hormone and growth hormone receptor in fibroadenoma tissue indicates their possible role in the pathogenesis of this tumor. Follow up of patients with high expression of growth hormone and growth hormone receptor may be suggested.
引用
收藏
页码:235 / 239
页数:5
相关论文
共 22 条
[1]   Growth hormone, the insulin-like growth factor axis, insulin and cancer risk [J].
Clayton, Peter E. ;
Banerjee, Indraneel ;
Murray, Philip G. ;
Renehan, Andrew G. .
NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (01) :11-24
[2]   Benign breast diseases [J].
Courtillot, Carine ;
Plu-Bureau, Genevieve ;
Binart, Nadine ;
Balleyguier, Corinne ;
Sigal-Zafrani, Brigitte ;
Goffin, Vincent ;
Kuttenn, Frederique ;
Kelly, Paul A. ;
Touraine, Philippe .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2005, 10 (04) :325-335
[3]   INSULIN-LIKE GROWTH-FACTOR EXPRESSION IN BREAST-CANCER EPITHELIUM AND STROMA [J].
CULLEN, KJ ;
ALLISON, A ;
MARTIRE, I ;
ELLIS, M ;
SINGER, C .
BREAST CANCER RESEARCH AND TREATMENT, 1992, 22 (01) :21-29
[4]   Physiology of the GH-IGF axis [J].
Eduardo Martinelli, Carlos, Jr. ;
Jose Custodio, Rodrigo ;
Herminio Aguiar-Oliveira, Manuel .
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2008, 52 (05) :717-725
[5]  
ELLIS IO, 2007, DIAGNOSTIC HISTOPATH, P906
[6]   Growth hormone receptor is expressed in human breast cancer [J].
Gebre-Medhin, M ;
Kindblom, LG ;
Wennbo, H ;
Törnell, J ;
Meis-Kindblom, JM .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (04) :1217-1222
[7]   Pit-1 is expressed in normal and tumorous human breast and regulates GH secretion and cell proliferation [J].
Gil-Puig, C ;
Seoane, S ;
Blanco, M ;
Macia, M ;
Garcia-Caballero, T ;
Segura, C ;
Perez-Fernandez, R .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 153 (02) :335-344
[8]   Expression of growth hormone receptor in benign and malignant cutaneous proliferative entities [J].
Ginarte, A ;
García-Caballero, T ;
Fernández-Redondo, V ;
Beiras, A ;
Toribio, J .
JOURNAL OF CUTANEOUS PATHOLOGY, 2000, 27 (06) :276-282
[9]   Circulating concentrations of insulin-like growth factor-I and risk of breast cancer [J].
Hankinson, SE ;
Willett, WC ;
Colditz, GA ;
Hunter, DJ ;
Michaud, DS ;
Deroo, B ;
Rosner, B ;
Speizer, FE ;
Pollak, M .
LANCET, 1998, 351 (9113) :1393-1396
[10]   Acromegaly and cancer: A problem [J].
Jenkins, PJ ;
Besser, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (07) :2935-2941